GILDER GAGNON HOWE & CO LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.7%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$0
-100.0%
290.0%0.00%
Q3 2021$1,0000.0%290.0%0.00%
Q2 2021$1,0000.0%290.0%0.00%
Q1 2021$1,0000.0%29
-29.3%
0.00%
Q4 2020$1,000
-100.0%
41
-99.9%
0.00%
-100.0%
Q3 2020$2,331,000
-66.1%
61,816
-61.5%
0.01%
-74.1%
Q2 2020$6,873,000
+11957.9%
160,520
+7256.6%
0.05%
+5300.0%
Q4 2019$57,000
-3.4%
2,1820.0%0.00%0.0%
Q3 2019$59,0000.0%2,1820.0%0.00%0.0%
Q2 2019$59,000
-6.3%
2,1820.0%0.00%0.0%
Q1 2019$63,000
+5.0%
2,182
-1.8%
0.00%0.0%
Q4 2018$60,0002,2230.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders